Empresa SenzaGen AB Nasdaq Stockholm
Acciones
SE0010219626
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Genomic Allergen Rapid Detection
100,0
%
| 42 | 100,0 % | 50 | 100,0 % | +19,39 % |
Ventas por región
SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 42 | 100,0 % | 50 | 100,0 % | +19,39 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Peter Nählstedt
CEO | Chief Executive Officer | 50 | 01/01/18 |
Marianne Olsson
DFI | Director of Finance/CFO | 63 | 01/11/16 |
Henrik Johansson
CTO | Chief Tech/Sci/R&D Officer | 42 | 01/01/14 |
Director/Board Member | 59 | 15/10/14 | |
Public Communications Contact | 56 | 01/01/18 | |
Helen Olsson
HRO | Human Resources Officer | 59 | 01/01/20 |
Corporate Officer/Principal | 51 | 01/01/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 76 | 18/08/10 | |
Director/Board Member | 59 | 15/10/14 | |
Paula Zeilon
BRD | Director/Board Member | 62 | 01/01/20 |
Director/Board Member | 65 | 01/01/20 | |
Peter Nählstedt
CEO | Chief Executive Officer | 50 | 01/01/18 |
Ian Kimber
BRD | Director/Board Member | 74 | 01/01/15 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 24 188 325 | 14 889 392 ( 61,56 %) | 0 | 61,56 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-20,45 % | 10,82 mil M | |
+43,17 % | 3251,13 M | |
-35,86 % | 2114,71 M | |
-17,21 % | 2080,91 M | |
-29,81 % | 1476,2 M | |
+17,56 % | 1021,44 M | |
-4,37 % | 733 M | |
-37,00 % | 391 M | |
-46,94 % | 383 M |